MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Total Assets 2011-2026 | EW
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.7 B | 13.1 B | 9.36 B | 8.29 B | 8.5 B | 7.24 B | 6.49 B | 5.32 B | 5.7 B | 4.51 B | 4.06 B | 3.52 B | 2.72 B | 2.22 B | 1.98 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.7 B | 1.98 B | 6.45 B |
Quarterly Total Assets Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.3 B | 13.5 B | 13 B | 13.1 B | 13 B | 10.1 B | 9.74 B | 9.36 B | 9.37 B | 9 B | 8.65 B | 8.29 B | 8.64 B | - | 8.42 B | 8.5 B | 8.16 B | 7.66 B | 7.21 B | 7.24 B | 7.24 B | 7.24 B | 7.24 B | 6.49 B | 6.49 B | 6.49 B | 6.49 B | 5.32 B | 5.32 B | 5.32 B | 5.32 B | 5.67 B | 5.67 B | 5.67 B | 5.65 B | 4.51 B | 4.51 B | 4.51 B | 4.51 B | 4.06 B | 4.06 B | 4.06 B | 4.06 B | 3.52 B | 3.52 B | 3.52 B | 3.52 B | 2.71 B | 2.71 B | 2.71 B | 2.71 B | 2.22 B | 2.22 B | 2.22 B | 2.22 B | 1.98 B | 1.98 B | 1.98 B | 1.98 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.5 B | 1.98 B | 6.1 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.3 | -4.96 % | $ 6.38 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 166.05 | -6.36 % | $ 12.4 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Sensus Healthcare
SRTS
|
53 M | $ 3.79 | -5.61 % | $ 61.9 M | USA |
 |
Stryker Corporation
SYK
|
47.8 B | $ 328.87 | -1.15 % | $ 126 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 10.97 | -4.78 % | $ 1.65 B | USA |
 |
Tactile Systems Technology
TCMD
|
274 M | $ 26.49 | -1.08 % | $ 606 M | USA |
 |
TELA Bio
TELA
|
81.4 M | $ 0.67 | -10.47 % | $ 31.5 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
470 M | $ 0.38 | 1.99 % | $ 39.1 M | USA |
 |
Abbott Laboratories
ABT
|
86.7 B | $ 104.91 | 0.33 % | $ 183 B | USA |
 |
Tandem Diabetes Care
TNDM
|
881 M | $ 21.24 | -8.92 % | $ 1.44 B | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 69.46 | -1.01 % | $ 103 B | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 35.4 | -3.38 % | $ 1.1 B | USA |
 |
Establishment Labs Holdings
ESTA
|
357 M | $ 56.7 | -5.36 % | $ 1.68 B |  Costa-rica |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
3.63 M | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Viemed Healthcare
VMD
|
199 M | $ 9.27 | 0.54 % | $ 361 M | USA |
 |
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.61 | 1.65 % | $ 33.2 M | USA |
 |
Aethlon Medical
AEMD
|
7.36 M | $ 2.14 | -5.73 % | $ 3.34 M | USA |
 |
Varex Imaging Corporation
VREX
|
1.11 B | $ 10.82 | 0.32 % | $ 448 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Beyond Air
XAIR
|
30.1 M | $ 0.72 | 4.06 % | $ 48.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
93.8 M | $ 0.55 | -2.12 % | $ 73.5 M | USA |
 |
Inogen
INGN
|
299 M | $ 6.29 | -3.31 % | $ 167 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
21.4 B | $ 88.46 | -0.77 % | $ 18 B | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 11.16 | -2.19 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.81 | -3.3 % | $ 371 M | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
16.8 M | - | 10.0 % | $ 610 K | USA |